Introduction
The diagnosis and identi¢cation of blood parasites is becoming ever more important with the increase in imported parasitic disease in the temperate zone. Any clinical haematology laboratory can expect to be called upon to diagnose these parasites, especially malaria, and a high level of competence is required. This review considers the imported blood parasites that could be encountered and discusses the merits of the various diagnostic tests available.
Protozoa

Malaria
The accepted laboratory procedure for the diagnosis of malaria is the preparation and examination of Giemsa or Field's stained blood smears under the light microscope (Warhurst & Williams 1996; General Haematology Workforce1997) . Smears may be prepared directly from a ¢nger prick blood sample. Venipuncture specimens collected in EDTA coated tubes are also acceptable, but must be examined promptly to prevent alteration of parasite morphology due to the sequestrine e¡ect. Both thick and thin smears should be made. The thick smear, which increases by a factor of 20^30 the number of red blood cells per given area on the slide compared to the thin ¢lm, is much more sensitive than the thin ¢lm for detection of a malarial infection. The thin smear is superior to the thick for speciation.
This technique has undergone very little improvement over the last 100 years. Although considered the gold standard, diagnosis of malaria using blood ¢lms can be problematic; it requires up to 60 min of preparation time, is labour intensive and interpretation of the result requires considerable expertise, particularly at low levels of parasitaemia Warhurst & Williams (1996) . In addition, in patients with Plasmodium falciparum malaria, the parasites are sequestered in tissue capillaries for part of the asexual cycle and, in a synchronous infection with this species, may not always be present in the peripheral blood. Thus a P. falciparum infection might be missed unless blood samples are repeated daily, or more frequently if the clinical picture dictates. Furthermore, detection of parasites by blood ¢lm on follow-up of treatment does not assess their viability (Srinavasan et al. 2000) . Warhurst & Williams (1996) discuss several methods employed to quantify malaria parasites in thick blood smears. One technique is to count the total number of parasites per 200 white blood cells (WBC) and multiply this number by 40 to give the number of parasites/ml, assuming that there are 8000 WBC/ml blood. A second method involves making a thick smear with a known volume of blood (5 ml), and staining with Giemsa stain before counting all the parasites on the smear. The total parasite count is divided by 5 to obtain the number of parasites/ml. A similar technique again uses a de¢ned amount of whole blood to make a thick smear and then the parasites present in 100 high-power ¢elds (HPF) are counted. One parasite/100 HPF is assumed to be the equivalent to 50 parasites/ml. A thick smear is generally considered negative if no parasites are seen after 10 min searching. Parasite levels may also be quanti¢ed by examination of a thin blood smear. This is usually accomplished by counting the number of parasites/1000 red blood cells (RBC) and expressing as a percentage the number of erythrocytes infected, or again, by counting the number of parasites per 200 WBC as described for the thick ¢lm. 189
Assessment of parasitaemia by examination of blood smears
A weakness in the estimation of parasite levels by counting parasites against a particular number of WBC is the assumption that all blood samples contain 8000 WBC/ml. If a suitable instrument is available, it is much better to count the WBC/ml of each blood sample under investigation, and so obtain an accurate conversion factor for each sample. For example, if there are 10 parasites/ 200 WBC and the total WBC is 10 000/ml then there are 500 parasites [i.e. (10 000/200) Â 10] parasites/ml.
The major disadvantage of the thick smear is that it is di¤cult to read and the necessary expertise may be unavailable. Using one method to evaluate the intensity of the infection, the examiner should, in theory, only count thick-smear ¢elds containing 20 WBC/HPF. In reality, ¢elds containing 20 WBC are often too thick to count accurately, whereas the ¢elds that are easiest to read are those that contain only ¢ve or six WBC each. It has been suggested that the microscopist should be able to read print through a well-prepared, thick blood smear before it is stained. Warhurst & Williams (1996) report that examination of thin blood smears is only one tenth as sensitive as examination of thick blood smears for the quanti¢ca-tion of malarial parasites, although identi¢cation of the Plasmodium species present is much easier using thin smears. Most laboratories involved in the identi¢cation and quanti¢cation of malaria parasites by microscopy therefore produce both thick and thin blood smears. In conclusion, even though examination of blood smears is accepted as the current, universal`gold standard' for malaria diagnosis, no single method for estimation of parasitaemia is used by all investigators, which can lead to di¤culties in comparing data between di¡erent studies (Hanscheid & Valadas1999) .
Fluorescent microscopy
Three techniques using £uorescence of the parasite for the diagnosis of malaria have been described. The quantitative bu¡y coat or QBC11 1 method (Baird et al. 1992; Benito et al. 1994; Clendeman, Long & Baird 1995) which is available as a commercial kit (Becton Dickinson, Franklin Lakes, NJ, USA); the Kawamoto acridine orange process (Kawamoto 1991a; Kawamoto 1991b; Kong & Chung 1995; Bosch et al. 1996; Gay et al. 1996; Lowe et al. 1996) and the use of benzothiocarboxypurine (BCP) (Makler et al. 1991; Cooke et al. 1992) . These three techniques are rapid and relatively easy to perform (when there are > 100 parasites/ml) and demonstrate sensitivity and speci¢-city equivalent to those achievable by examination of stained thick smears.
Both the QBC and Kawamoto methods use acridine orange (AO) as the £uorochrome to stain the nucleic acids of any malaria parasites in the sample. BCP is another £uorochrome which stains nucleic acids. Although AO is a very intense £uorescent stain, it is nonspeci¢c and stains nucleic acids from all cell types. Consequently, the microscopist using AO has to learn to distinguish £uores-cent-stained parasites from other cells and cellular debris containing nucleic acids. The sensitivity of AO staining at parasite levels of <100 parasites/ml has been reported to range from 41.1% to 93% (Delacollett & VanderStuyft 1994) . The speci¢city of AO staining for P. vivax infections was reported to be about 52%, whereas that for P. falciparum infections was around 93% (Hakim et al. 1993) . The BCP method has a reported sensitivity and speci¢city of > 90% (Cooke et al. 1993 ). An important limitation of methods based on AO and BCP is their inability to di¡er-entiate easily between Plasmodium spp. In addition, AO is considered hazardous and has special disposal requirements.
Comparing methodologies, both the QBC and the BCP £uorescent methods are more demanding technically than the Kawamoto AO method (Hakim et al. 1993; Hind et al. 1994) and require special equipment and supplies. The QBC method requires a particular centrifuge and haematocrit tubes and was reported to increase costs to about US$ 1.70/sample (Craig & Sharp 1997) . The BCP method also requires a good £uorescent microscope, with a high intensity mercury vapour or quartz halogen lamp. The simpler Kawamoto method employs a pair of £uores-cence ¢lters and readily available AO and can make use of the sunlight as the exciting light source (if a shield to surround the observer's eyes is used). If sunlight is not used this technique also requires a high-intensity halogen lamp.
In spite of its limitations, including the requirements for special training, expensive equipment and supplies, £uorescence microscopy for the rapid detection of malaria parasites in blood is a viable alternative to examination of Giemsa stained smears.
Detecting specific nucleic-acid sequences
Another approach to the laboratory diagnosis of malaria is based on the detection of nucleic acid sequences speci¢c to Plasmodium. Several PCR assays have been developed for the diagnosis of malaria. The 18S rRNA gene has been used as a target for the di¡erentiation of Plasmodium species by nested PCR and reverse transcription-PCR (Barker et al. 1992; Snounou et al. 1993) . Other DNA targets such as the circumsporozoite protein gene have also been investigated for species speci¢c regions. The large-subunit rRNA gene is extensively conserved within Plasmodium species and is suitable as a genus-speci¢c target region; the ampli¢ed target sequence is detected by internal probes or analysed by gel electrophoresis (Kain et al. 1993) . The major advantage of using a PCR-based technique is the ability to detect infection in patients with low parasitaemia; infection with ¢ve parasites/ml can be detected with 100% speci¢city (Kawamoto et al. 1996) . PCR-based techniques have been used to screen blood donors in Ho Chi Minh City, Vietnam, an area where malaria is endemic.
The sensitivity of PCR-based methods is greater than microscopy and, following treatment, PCR yields positive results longer than microscopic examination (Kain et al. 1994) . Several workers have investigated the persistence of parasite DNA in peripheral blood following antimalarial treatment. In one report, PCR remained positive for a median of 144 h compared to 66 h for microscopy (Sethabutr et al. 1992; Seesod et al. 1993) . Such microscopically negative but PCR positive specimens probably had either subpatent parasitaemia or circulating P. falciparum DNA. Kain et al. (1994) also reported that if PCR yields positive results for 5^8 days after treatment, therapeutic failure, possibly due to drug resistance, might be predicted.
The variable PCR results in di¡erent studies (Table 1 ) re£ect a number of variations in PCR technique from collection and storage of the specimens, DNA extraction, selection of primers, ampli¢cation conditions, and analysis of ampli¢ed product. Further advances in PCR technology may soon allow viable parasites to be distinguished from nonviable and facilitate use of PCR-based procedures in the ¢eld (Wataya et al. 1993) . Although PCRbased methods are arguably the most sensitive method for detection of patent malarial infections, they are also particularly useful for studies on strain di¡erences, mutations, and genes involved in drug resistance in the parasites and to show the relationship between strains associated with di¡erent outbreaks of malaria. Use of PCR-based technology for malaria diagnosis may therefore become clinically relevant for acute diagnosis in both ¢eld and reference laboratory situations.
Antigen detection
Although alternative methods to stained blood ¢lms for diagnosis of malaria have been around for a considerable time (Taylor & Voller 1993) , the original £uorescent antibody detection tests for malaria were limited in sensitivity and in their ability to distinguish active from prior infections. The new generation antigen capture tests are capable of detecting fewer parasites and of producing a more rapid result (10^15 min). They are commercially available as kits, which include all the necessary reagents, and do not require extensive training or equipment to perform or to interpret their results.
Two parasite antigens are currently used in the new, rapid immunochromatographic tests: Histidine-rich protein-2 (HRP-2) (Rock et al. 1987) , a water-soluble protein which is expressed by P. falciparum and parasite lactatedehydrogenase (pLDH) antigen , present as separate isomers for all four Plasmodium species infecting humans. Both of these antigens are also produced by gametocytes (Odoula et al. 1987; Kilian et al. 1997) . The latest antigen capture tests are rapid and simple to perform, and have detection limits comparable to those of high-quality microscopy (i.e. 100^200 parasites/ ml).
HRP-2 immunochromatography-based assays
At parasitaemias of 60^100 parasites/ml, the HRP-2 based tests are > 90% sensitive and > 90% speci¢c for P. falciparum, compared with thick-smear microscopy Both tests can be performed on ¢nger-prick blood samples. They deploy labelled monoclonal antibodies to HRP-2 in a mobile phase, to capture HRP-2 antigen from P. falciparum and a further stripe of anti HRP-2 antibody immobilized onto nitro-cellulose strips, to capture labelled antigens in a dipstick format. In each test, a positive result is indicated by the appearance of a red line on the test strip at the site where the monoclonal antibodies are immobilized. Both tests also contain a built-in control line, which must appear for the test to be considered valid.
A comparison of the ParaSight 1 F antigen-capture test with PCR-based diagnosis (Peyron et al. 1994 ) gave a reported sensitivity and speci¢city of the ParaSight 1 Ftest of 80% and 97%, respectively, compared with the results of PCR.
Other studies on the sensitivity and speci¢city of the ParaSight 1 F-test for the detection of Plasmodium falciparum in blood samples. Schi¡ et al. 1993; Beadle et al. 1994; Miller et al. 1994; Peyron et al. 1994; Premji et al. 1994; Dietz et al. 1995; Verle et al. 1996; Kodisinghe et al. 1997; Singh et al. 1997) have shown an average sensitivity of 77^98% and speci¢city of 83^99%. Although HRP-2-based immunochromatographic tests permit rapid diagnosis of P. falciparum malaria, they do have limitations in their use. Firstly, since HRP-2 is only expressed by P. falciparum, tests based on the detection of HRP-2 give negative results for samples containing P. vivax, P. ovale or P. malariae. Thus, cases of nonfalciparum malaria may be misdiagnosed as malaria-negative if the only diagnostic test used is based upon HRP-2 detection. Another limitation is the persistence in the blood of HRP-2 after the clinical symptoms of malaria have disappeared and the parasites have apparently been cleared from the host. Results of investigations with the ParaSight 1 F-test on blood taken 0^14 days after treatment of falciparum malaria with artemether showed persistence of HRP-2 in 16 of 75 blood samples at day 14 after treatment had ¢nished.
Tests for HRP-2 may therefore be di¤cult to interpret when screening indigenous people of malaria-endemic areas, who may have persistent, low-level parasitaemia, yet not be ill (Verle et al. 1996) . The reason for the persistence of the HRP-2 antigens is not well understood; it may re£ect the presence of latent, viable parasites (possibly the result of treatment failure) or of soluble, antigen/antibody complexes (Humar et al. 1997) . The persistence may also depend upon the type of antimalarial therapy instituted. Schi¡ et al. (1993) noted that10% of patients treated with Fansidar 1 had detectable HRP-2 antigen on day 14.
Using the ParaSight 1 F-test to investigate 19 patients given unspeci¢ed antimalarial chemotherapy, Humar et al. (1997) detected HRP-2 antigen in 68% of the patients on day 7 after initiation of treatment and in 27% on day 28. The HRP-2 signal has been shown to persist for 19 days after apparently e¡ective quinine therapy. Karbwang et al. (1996) also detected persistent HRP-2 antigen during and after artemether therapy, acknowledging that the HRP-2 signal was of no value during the ¢rst week of treatment but appeared to be a precise indicator of treatment failure under`¢eld'conditions, when it was detected on day 14 post-treatment. More studies are required in this area.
Other limitations are speci¢cally related to technical aspects of the test system. For example, the monoclonal IgG antibody utilized in the ParaSight 1 F may cross-react with serum rheumatoid factor and be the cause of a falsepositive response (Laferi et al. 1997) .
pLDH-based immunochromatographic assays
Parasite lactate dehydrogenase (pLDH) Piper et al. 1996 ) is a glycolytic enzyme present in all species of malaria parasites of humans. Furthermore, pLDH from P. falciparum can be assayed in the presence of host LDH utilizing the coenzyme 3-acetylpyridine adenine dinucleotide (APAD), an analogue of nicotinamide adenine dinucleotide (NAD) (Piper et al. 1999) . Although the Michaelis^Menten constants (k m ) are similar, the k eat (turnover number) of pLDH in the presence of APAD is much greater than that of the human enzyme with the same coenzyme (Gomez et al. 1997) . This characteristic is due in part to conformational changes that occur in the enzyme (Dunn et al. 1996) . pLDH-based assays are available in two formats: a semiquantitative, dry dipstick (OptiMAL 1 , Flow Inc., Portland, OR, USA) and a 96 well, quantitative, immunoenzymatic capture, plate assay (Piper et al. 1999) . The latter technique captures pLDH on a microtitre plate with a speci¢c anti pLDH monoclonal antibody, then quanti¢es the amount of enzyme captured with an enzyme reaction utilizing APAD. The bound pLDH activity correlates well with viable parasite density on initial diagnosis. But the pLDH activity has also been shown to parallel the level of viable parasites during therapy (Makler & Heinrichs 1993; Gomez et al. 1997; Piper et al. 1999) . The latter observation is especially important, since this assay could thus be used to follow patient progress during antimalarial therapy, and alert the physician to the presence of a drug-resistant infection if pLDH levels fail to decline in sequential samples.
Low levels of pLDH cannot easily be measured colourimetrically by this enzymatic method because of the presence of nonspeci¢c reductases in blood lysates. Because of this, two assays have been formatted that utilize monoclonal antibodies (mAbs) which capture the pLDH. These mAbs were raised against pLDH puri¢ed from P. falciparum infected erythrocytes. They vary in respect of their reactivity with pLDH isoforms from the di¡erent human malarial species. Two of the mAbs are pan-speci¢c, recognizing all four species of malaria. A third mAb recognizes only P. falciparum LDH isoforms. The monoclonal antibodies utilized in the OptiMAL 1 test have been exhaustively tested for cross-reactivity with LDH from Leishmania, Babesia and pathogenic bacteria or fungi and no evidence of such cross-reactivity has been found (Makler & Heinrichs1993) . The immunochromatographic strip test (OptiMAL 1 ) which is based on these mAbs uses a gold-conjugated pan-speci¢c antibody (6C9) to capture pLDH from all species of Plasmodium from humans. The blood/antibody complex travels along a nitro-cellulose strip on which are two further monoclonal antibody capture stripes, one speci¢c for P. falciparum (17E4) and a second pan-speci¢c monoclonal antibody (19G7) for capturing all four Plasmodium species. A goat antimouse monoclonal antibody capture control line is present to indicate a successfully performed test. The gold conjugated antigen/antibody complex builds as a red line at the capture stripe. The presence of three lines (control pan-speci¢c Pf speci¢c) indicates P. falciparum antigen captured. Two lines (control pan-speci¢c but not Pf speci¢c) indicates a species other than P. falciparum.
Trials of the OptiMAL 1 test have been undertaken in many centres (John et al. 1998; Palmer et al. 1998; Quitana et al. 1998; Hunt Cooke et al. 1999; Moody et al. 2000) and have reported sensitivities of 92^98%, with a speci¢city of 94%, for P. falciparum and a sensitivity of 96% for P. vivax.
Studies to evaluate pLDH levels in sequential blood samples taken from patients undergoing antimalarial chemotherapy demonstrated that pLDH levels followed peripheral parasitaemia and fell to undetectable values 3^5 days after quinine therapy, which could provide a valuable tool in monitoring antimalarial therapy (Srinavasan et al. 2000) . Clearance of parasitaemia and clearance of pLDH appear to parallel each other.
In the past few years, e¡orts to replace the traditional and tedious reading of blood smears have led to techniques for the detection of malaria parasites with a sensitivity equivalent to or better than microscopy (Taylor & Voller 1993) . Immunochromatographic dipsticks o¡er the possibility of a more rapid, nonmicroscopic method for malaria diagnosis, thereby saving on training and time.
Babesiosis
Babesiosis is caused by haemoprotozoan parasites of the genus Babesia. While more than 100 species have been reported, only a few have been shown to cause human infection. Babesia microti and Babesia divergens have been identi¢ed in most human cases (Hoare 1980) , but variants (considered di¡erent species) have been seen in malariaendemic areas where Babesia can easily be misdiagnosed as Plasmodium.
In the north-eastern USA, the blacklegged deer tick (Ixodes scalpularis) is the principal vector transmitting the aetiologic agent, Babesia microti. This tick is also the primary vector of the Lyme disease spirochaete, Borrelia burgdorferi (Benach & Habicht 1981) . In areas where these diseases are endemic, concurrent infections by both pathogens in P. leucopus and in I. scapularis are common, but far fewer cases of human babesiosis have been reported than Lyme disease. Most Babesia microti infections are probably asymptomatic (Ruebush et al. 1977) , as indicated by serological surveys. Manifestations of disease include fever, chills, sweating, myalgias, fatigue, hepato-splenomegaly and haemolytic anaemia. Symptoms typically occur after an incubation period of 1^4 weeks, and can last several weeks. The disease is more severe in patients who are immunosuppressed, splenectomized, and/or elderly. Previous splenectomy is the major risk factor for human infection with B. divergens and cases tend to be more severe (frequently fatal) than those due to B. microti, where clinical recovery usually occurs.
Diagnosis. Babesia microti and Babesia divergens are intraerythrocytic parasites and examination of Giemsastained blood smears is considered the most useful diagnostic procedure. The tetrad (Maltese cross) forms of Babesia microti are a primary diagnostic characteristic for infection with this species. However, the predominant form in most blood smears closely resembles ring stages of Plasmodium spp. (Garnham 1980) , with small to large cytoplasmic vacuoles. Therefore, it is sometimes di¤cult to di¡erentiate Babesia microti from Plasmodium spp., especially early ring stages of Plasmodium falciparum.
Methods for the detection of blood parasites
# 2000 Blackwell Science Ltd., Clin. Lab. Haem., 22, 189^202 Unlike Plasmodium, Babesia does not form pigment. Babesia divergens forms characteristic widely divergent pyriform pairs at the periphery of the erythrocyte and this species of Babesia should be less easily confused with malaria parasites.
Babesia infections in humans trigger humoral immune responses. An indirect immuno£uorescent antibody (IFA) assay can been used for the diagnosis of clinical cases. Although high titres have been detected in patients during the acute phase, a cut-o¡ point of1: 64 is generally accepted as diagnostic in IFA testing (Ruebush et al. 1977) . The B. microti IFAT has a reported sensitivity of 88^96% and speci¢city of 90^100%.
Sub-inoculation of blood samples from patients into hamsters may provide a diagnosis by amplifying the parasitaemia. In addition, the use of the polymerase chain reaction (PCR) has proven to be useful in the diagnosis of zoonotic Babesia infections. By using genus-and speciesspeci¢c primers, a de¢nitive diagnosis can be made within a day. In areas endemic for Babesia microti, the infection rates in mouse populations can reach as high as 60%.
Ehrlichiosis
During the past 10 years, two tick-borne diseases caused by Ehrlichia spp. have been recognized in the United States. Human Monocytic Ehrlichiosis (HME) was ¢rst described in 1986. It is caused by E. cha¡eensis, which was only identi¢ed in 1991. Human Granulocytic Ehrlichiosis (HGE), an alternative form of HME, was recognized as a new disease in 1993. Its causative agent is still uncertain, though it is similar to Ehrlichia equi described from horses.
Ehrlichiosis is characterized by fever associated with the presence of clusters of small organisms seen in circulating monocytes on Giemsa staining. Serology by IFA using E. cha¡eensis infected cells is the preferred method of diagnosis (Taylor et al. 1998) .
Trypanosomiasis
African trypanosomes are protozoan haemo£agellates belonging to the Trypanosoma brucei complex. Two morphologically indistinguishable subspecies cause distinct disease patterns in humans; T. b. gambiense causes West African sleeping sickness and T. b. rhodesiense causes East African sleeping sickness. A third member of the complex, T. b. brucei, does not infect humans under normal conditions.
Life cycle. T. brucei is transmitted by tsetse £ies of the genus Glossina. The £y ingests parasites when it takes a blood meal from an infected mammal. The parasites multiply in the £y, going through several developmental stages in the insect gut and salivary glands (procyclic trypanosomes, epimastigotes, and metacyclic trypanosomes). The cycle in the £y takes approximately 3 weeks. When the £y bites another mammal, metacyclic trypanosomes are inoculated, and multiply in the host's blood and extracellular £uids such as cerebro-spinal £uid (Omerod 1979) . Humans are the main reservoir for T.b. gambiense, whilst wild game animals are the main reservoir for T. b. rhodesiense.
T. b. gambiense is found in foci in large areas of West and Central Africa. The distribution of T. b. rhodensiense is much more limited, being found in East and South-east Africa.
Clinical features. Infection occurs in three stages. A trypanosomal chancre can develop at the site of inoculation. This is followed by a haemolymphatic stage with symptoms that include fever, lymphadenopathy, and pruritus. In the meningoencephalitic stage, invasion of the central nervous system can cause headaches, somnolence, abnormal behaviour and lead to coma. The course of infection is much more acute with T. b. rhodensiense than withT. b. gambiense.
Laboratory Diagnosis. The diagnosis rests upon demonstrating trypanosomes by microscopic examination of chancre £uid, lymph node aspirates, blood, bone marrow, or, in the late stages of infection, cerebrospinal £uid. A wet preparation of blood or where indicated CSF, should be examined for motile trypanosomes in addition to a ¢xed smear stained with Giemsa (or Field's) stain. Concentration techniques can be used prior to microscopic examination. For blood samples, these include Giemsa staining of thick blood smears, examination of Giemsa stained bu¡y coat preparations from haematocrit tubes (Woo & Hawkins 1975) or use of the quantitative bu¡y coat (QBC 1 ) technique. Mini anion-exchange columns, which use the di¡erence in electrical charge on the surface of the trypanosomes from that of the blood cells to e¡ect a separation on an anion-exchange chromatography column (Lumsden et al. 1979 ) detects as few as 5^10 trypomastigotes per millilitre of blood. For other samples such as cerebrospinal £uid, concentration techniques include centrifugation followed by examination of the sediment. Isolation of the parasite by inoculation of rats The card indirect agglutination test for trypanosomiasis (CIATT) is a rapid, simple test, which is based on the detection of trypanosome antigens. The test has undergone evaluation in a multi centre study carried out in Ghana, Coª te d'Ivoire,Tanzania and Uganda (Penchenier et al. 1991; Enyaru et al. 1998; Akol et al. 1999) . Results from the CIATT agree well (60^90% concordance) with results from PCR tests.
American trypanosomiasis
Life cycle. The protozoan parasite, Trypanosoma cruzi, causes Chagas' disease, a zoonotic disease that can be transmitted to humans by blood-sucking reduviid bugs. The reduviid bugs become infected by feeding on human or animal blood that contains circulating parasites. The parasites multiply and di¡erentiate in the insect gut, yielding infective metacyclic trypomastigotes. During a subsequent blood meal on a second vertebrate host, trypomastigotes are released in the insect faeces near the site of the bite wound. The host becomes infected through breaks in the skin, mucous membranes or conjunctivae. Inside the host, the trypomastigotes circulate in the peripheral blood and eventually invade the host cells, particularly striated muscle and gut tissue, where they di¡erentiate into intracellular amastigotes. The amastigotes multiply and di¡erentiate into trypomastigotes, which are released into the circulation as blood stream trypomastigotes. The blood stream trypomastigotes do not replicate (di¡erent from the African trypanosomes). Replication resumes only when the parasites enter another cell or are ingested by another vector.
T. cruzi can also be transmitted through blood transfusion, transplancentally, and in laboratory accidents.
Chronic Chagas' disease is a major health problem in many Latin American countries. With increased population movements, the possibility of transmission by blood transfusion has become more substantial, for example in the United States.
Clinical features. A local lesion (Chagoma) can appear at the site of inoculation. The acute phase is usually asymptomatic, but can present with manifestations that include fever, anorexia, lymphadenopathy, mild hepatosplenomegaly, and myocarditis. Most acute cases resolve over a period of 2^3 months into an asymptomatic chronic stage. The symptomatic chronic stage may not occur for years or even decades after initial infection. Its manifestations include cardiomyopathy (the most serious manifestation), megacolon and megaoesophagus.
Laboratory Diagnosis. Demonstration of the parasite is the diagnostic procedure of choice in acute Chagas' disease. Trypanosomes may be seen on microscopic examination of fresh anticoagulated blood, or fresh bu¡y coat for motile parasites, which are seen only in the early acute stage of the infection. Examination of thin and thick blood smears stained with Giemsa stain may reveal trypomastigote stage organisms, characterized by their typical c'shape and large kinetoplast.
Isolation of the agent may be undertaken by: (a) inoculation into mice (b) culture in specialized media (e.g. NNN medium). Xenodiagnosis, where uninfected reduviid bugs are fed on the patient's blood and the bug's gut contents examined for parasites 4 weeks later, is occasionally used.
Serology is the diagnostic method usually deployed for the chronic phase of the infection when the trypomastigotes have virtually disappeared from the peripheral blood. ELISA, IFAT and several agglutination methods are available.
Recent studies have focused on the sero prevalence of T. cruzi in blood donors at risk from infection, an area where more work is needed (Leiby et al. 1999) .
Leishmaniasis
Leishman and Donovan (Leishman 1903 ) ¢rst described the parasite causing visceral leishmaniasis in 1903, each separately demonstrating parasites in stained smears from the spleen of patients su¡ering from a malaria-like illness. This became known as visceral leishmaniasis and its causative agent was named Leishmania donovani. In 1908 Nicolle reported that mammals including dogs could act as reservoir hosts for Leishmania. In 1927, Adler & Theodar using human volunteers, proved that the leishmania parasite could be transmitted by phlebotomine sand£ies.
Trypanosomatid parasites of the genus Leishmania give rise to a variety of disease manifestations, collectively known as leishmaniasis. Leishmaniasis is prevalent throughout the tropical and subtropical regions of Africa, Asia, the Mediterranean, Southern Europe (Old World) and South and Central America (New World). It is estimated that approximately 12 million people are currently infected and a further 367 million in 88 countries are at risk of acquiring leishmaniasis, 72 are developing countries, 13 of them are among the least developed in the Methods for the detection of blood parasites # 2000 Blackwell Science Ltd., Clin. Lab. Haem., 22, 189^202 world. The annual incidence rate is estimated to be 1^1.5 million cases of cutaneous leishmaniasis and 500 000 cases of visceral leishmaniasis.
Visceral leishmaniasis or Kala-azar (Hindi: kala black, azar sickness). The aetiological agents belong to the Leishmania donovani complex, L. d. donovani and L. d. infantum in the Old World and L. d. chagasi in the New World. The Old World species are transmitted by the sand£y vector Phlebotomus. Humans, wild animals and domestic animals are known to act as reservoir hosts. Lutzomyia longipalpis is the only sand£y vector that has been implicated in the transmission of the NewWorld species of Leishmania and wild and domesticated dogs are known to serve as reservoir hosts.Visceral leishmaniasis is endemic in the tropical and subtropical regions of Africa, Asia, the Mediterranean, Southern Europe, South and Central America. The distribution of VL in these areas however, is not uniform; it is patchy and often associated with areas of drought, famine and densely populated villages with little or no sanitation. In endemic areas children below the age of 15 are commonly a¡ected. In sporadic and epidemic cases of VL people of all ages are susceptible with males at least twice as likely to contract the disease than females, except those who have conferred immunity due to past infection. Ninety percent of VL cases occur in Bangladesh, India, Nepal and Sudan. In the Mediterranean basin 1.5^9% of AIDS patients develop visceral leishmaniasis and 25^70% of the adult VL cases are related to HIV infection. Both the New World and the Old World forms of the disease display similar symptoms and are often complicated by secondary infections.
The Leishmania life cycle. The sand£y vector becomes infected when feeding on the blood of an infected individual or an animal reservoir host. The leishmania parasites live in the macrophages as round, nonmotile amastigotes (3^7 micrometers in diameter). During the blood-meal, the sand£y ingests the macrophages and the amastigotes are released into the stomach of the insect. Almost immediately the amastigotes transform into the motile, elongated (10^20 mm) £agellate promastigote form. The promastigotes then migrate to the alimentary tract of the £y, where they live extracellularly and multiply by binary ¢ssion. Four to ¢ve days after feeding the promastigotes move forward to the oesophagus and salivary glands of the insect. When the sand£y next feeds on a mammalian host, its proboscis pierces the skin, saliva containing anticoagulant is injected into the wound to prevent the blood from clotting and the leishmania promastigotes are transferred to the host along with the saliva. Once in the host the promastigotes are taken up by macrophages where they rapidly revert to the amastigote form. The leishmania are able to resist the microbicidal action of the acid hydrolases released from the lysozymes and so survive and multiply inside the macrophages, eventually leading to their lysis. The released amastigotes are taken up by other macrophages and so the cycle continues. Ultimately all the organs containing macrophages and phagocytes are infected, especially the spleen, liver and bone marrow. The term Kala-azar, used to describe established VL, originally referred to IndianVL with its characteristic blackening or darkening of the skin of the hands, feet, face and abdomen (Lainson & Shaw1987) .
Visceral leishmaniasis can be complicated by serious secondary bacterial infections such as pneumonia, dysentery and pulmonary tuberculosis, which often contribute to the high fatality rate of VL patients. Other, rarer complications include haemolytic anaemia, acute renal damage and severe mucosal haemorrhage.
Preliminary diagnosis is based on the symptoms and clinical signs of visceral leishmaniasis such as splenomegaly, hepatomegaly and high undulating fever. However, these alone cannot di¡erentiate VL from other similar conditions such as malaria, relapsing fever, liver abscess and trypanosomiasis.
Parasitological diagnosis
Splenic aspirate or liver biopsy. Looking for parasites in the spleen and liver is one of the most accurate methods available to determine Leishmania infections. Splenic aspirate is preferred to liver biopsy.
Ninety percent of active cases show parasites in splenic aspirates. Part of the splenic aspirate can be used to make smears for direct microscopic examination and the rest should be cultured. L. donovani grows well on NovyM acNeal^Nicolle (NNN) or Schneider's insect medium supplemented 10% v/v foetal calf serum, although other suitable growth media can be used just as well. Liver biopsy material is less likely to demonstrate parasites on direct examination or on culture, but histological examination may show amastigotes in Kup¡er cells in the portal system.
Bone Marrow Aspirate. Bone marrow aspiration is a safer method than splenic aspirate or liver biopsy. It is less likely to demonstrate parasites in stained ¢lms (Williams 1995) , but on culture it can give positive results in up to 80% of cases. Lymph node puncture gives positive results in 60% of cases where lymph nodes are enlarged. Juice is extracted from any enlarged lymph gland and subjected to both direct examination and to culture to give the best chance of diagnosis.
Buffy coat. Finding Leishmania parasites in blood is sometimes possible in patients with Kala-azar from India. Blood in anticoagulant is centrifuged at 2000 g for 10 min and the cells from the bu¡y coat removed and used to prepare smears and inoculate cultures. Amastigotes can be found in and around macrophages. The volume used for inoculation of cultures is important; addition of 1^3 drops to NNN or Schneider's medium has given successful results (Lopez-Velez et al. 1995; Williams199) .
Serological diagnosis. The IFAT is one of the most sensitive tests available and is based on detecting antibodies, which are demonstrable in the very early stages of infection and undetectable 6 to 9 months after cure. If the antibodies persist in low litres it is an indication of a probable relapse. Titres above 1/20 are signi¢cant and above 1/128 are diagnostic (Williams 1995) . There is a possibility of a cross-reaction with antitrypanosomal antibodies. However, this can be overcome by using Leishmania amastigotes instead of promastigotes as the antigen (GariToussaint et al. 1994) .
Enzyme linked immunosorbent assay (ELISA). The ELISA test is reported to have a sensitivity of above 98%. The antigen is prepared from promastigotes of L. donovani and the test can be performed on serum, plasma or blood spots collected on ¢lter paper. It is useful in the ¢eld owing to its simplicity, but false positives are not uncommon. The IFAT and DAT are preferable for laboratory diagnosis (Lainson & Shaw1987) .
A rapid immunochromatographic test using rK39 antigen produced from the membrane of amastigotes has given useful results in the diagnosis of VL (Tebourski et al. 1994; Singh et al. 1995) .
Direct agglutination test. The DAT is a highly speci¢c and sensitive test. It is cheap and simple to perform making it ideal for both ¢eld and laboratory use. The antigen is prepared from promastigotes of L. donovani and test can be carried out on plasma, serum, blood spots and whole blood. Antibody titres of 1: 3200 are considered positive (El-Harith et al. 1995; El-Harith et al. 1996) .
Formol gel test . The formol gel test has the advantage of being cheap and simple to perform. Serum obtained from about 5 ml of blood is mixed with one drop of 30% formaldehyde. A positive reaction is shown if the mixture solidi¢es and forms a white opaque precipitate within 20 min. A positive test cannot be detected until 3 months after infection and becomes negative 6 months after cure.
The test is nonspeci¢c since it is based on detecting raised levels of IgG and IgM which also result from other infections such as African trypanosomiasis, malaria and schistosomiasis (Napier 1921) so it has very limited usefulness. Speci¢c tests are preferred Molecular probes. Recently, molecular probes, using kinetoplast DNA (kDaNA), ribosomal RNA (rRNA), mini exon derived RNA (medRNA) and genomic repeats have been evaluated. A probe has been developed to recognize the genomic DNA repeat Lmet2 that is speci¢c for L. donovani. This probe has been used to diagnose infection in human patients with VL and in Phlebotomus martini, the sand£y vector of L. donovani (Wilson 1995) . The early DNA probes were labelled with radioactive 32P, were easy to use and gave high signals with low background interference. However, these were not suitable as diagnostic kits, since 32P has a short half-life of about 14 days and, being radioactive, they presented safety problems. Recently, chemiluminescent hapten digoxigenin-labelled kDaNA probes have been developed. These probes are as sensitive as the 32P labelled probes (can detect as low as 100 parasites) and are stable enough to use in diagnostic kits, which are more practical in the ¢eld. However, high background signals make result interpretation di¤cult Simonsen & Dunyo 1999) . The latest developments in molecular diagnostic technology have come with the advent of the polymerase chain reaction (PCR). PCR is able to amplify small amounts of DNA or RNA to larger usable quantities (Nuzum et al. 1995;  Williams1995;Wilson1995)Á Although PCR is able to detect a single copy of target DNA, repeat sequences are used to improve sensitivity. The early PCR assays required gel electrophoresis to interpret results, which was time consuming and not suitable for ¢eld use. An improved PCR-solution hybridization enzyme linked assay (PCR-SHELA) was developed and has been used to diagnose infection of L. donovani in patients in India, Kenya and Brazil with 90% sensitivity and 100% speci¢city (Nuzum et al. 1995) . It has also been used as an epidemiological survey tool in Central America to detect the presence of L. chagasi. The PCR-SHELA Methods for the detection of blood parasites # 2000 Blackwell Science Ltd., Clin. Lab. Haem., 22, 189^202 makes use of a biotin labelled probe; the product can be detected using a spectrophotometer and the assay can be performed in microtitre plates (Wilson1995).
Helminths
Filariasis
Loa loa. Loiasis occurs principally in West Africa and the Sudan.
Life cycle. The insect vector is the deer £y Chrysops spp. which tend to inhabit swampy areas of the forest. After being ingested when the £y takes a blood meal, the larvae migrate to the fat bodies where they develop, before migrating to the mouthparts when they reach the infective L3 stage.
The adults of this ¢larial parasite live in the subcutaneous tissues of their de¢nitive hosts, which are humans and other primates. The females measure from 20 to 70 mm in length and 425 mm in diameter, with the males substantially smaller (20^34 mm long and 350 mm in diameter).
Loiasis is often asymptomatic but episodic oedematous subcutaneous swellings (Calabar swellings) and subconjunctival migration of an adult worm can occur. Larval stages (micro¢lariae) are discharged into the circulation.
Laboratory diagnosis. Laboratory diagnosis is made by demonstrating characteristic micro¢lariae in the blood. The micro¢lariae, which are sheathed, are found in the peripheral blood during the day with a peak between 1200 and 1400 h and in the lungs at night. Several methods are used to demonstrate and identify them, the most useful involving concentration by ¢ltering anticoagulated blood through a nuclepore 1 membrane of 5 mm-pore size to capture all the micro¢lariae. Con¢rmation can be obtained by staining the micro¢lariae with a combination of Giemsa stain and Dela¢eld's haematoxylin to show the presence of a sheath and nuclear extension to the end of the blunt tail. A signi¢cant increase in eosinophil numbers is seen during the development of adult worms but is nonspeci¢c (Dennis1993).
Serological techniques (ELISA or IFAT) utilizing extracts from whole worms or micro¢lariae as antigens, can be used to demonstrate ¢larial antibodies. Antibody detection is useful when the micro¢lariae cannot be demonstrated but the assays are not species-speci¢c and exhibit cross-reaction with several other ¢larial species.
The development and use of speci¢c monoclonal antibodies in an ELISA for the detection of circulating antigens will probably increase speci¢city of the assays.Work in Gabon (Toure et al. 1999 ) using serology for IgG4 and nested PCR demonstrated that Loa loa speci¢c DNA detection using nested-PCR ampli¢cation is the most sensitive method in detecting loaisis, particularly with occult infections without circulating micro¢lariae. Speci¢c DNA probes for ¢lariasis are not as useful for patient diagnosis as they are for epidemiological purposes.
Wuchereria bancrofti/Brugia malayi. The nematode parasites Wuchereria bancrofti, Brugia malayi and Brugia timori are the causative agents of human lymphatic ¢lar-iasis.
Infection with these parasites most often consists of asymptomatic micro¢laraemia. Some patients develop lymphatic dysfunction causing lymphoedema and elephantiasis (frequently in the lower extremities) and, with Wuchereria bancrofti, hydrocoele and scrotal elephantiasis. Episodes of febrile lymphangitis and lymphadenitis may occur. Individuals newly arrived in endemic areas can develop afebrile episodes of lymphangitis and lymphadenitis. An additional manifestation of ¢larial infection, mostly in Asia, is the pulmonary tropical eosinophilia syndrome, with nocturnal cough and wheezing, fever and eosinophilia Laboratory diagnosis. Based on ¢nding micro¢lariae in peripheral blood samples. Collection of the specimen is dictated by the periodicity of the micro¢laraemia, which is determined by the geographical origin of the infections. The micro¢lariae are seen nocturnally (2200^0200 h) in most areas, except for a few parts of the South Paci¢c, where Brugia timori occurs diurnally. Concentration techniques and ¢ltration can be used as described for Loa loa. A study in south-west Ethiopia (Dennis1993) claimed that ¢ltering 5 ml of day blood obviated the need to examine night blood, even though a high proportion of infected persons had very low numbers of circulating micro¢lar-iae.
A microhaematocrit tube technique using the QBC 1 system has been used successfully to diagnose ¢lariasis, the micro¢lariae being seen above the bu¡y coat, with the nuclei staining with AO under ultra violet light (Long et al. 1990) . Three new commercially available tools for diagnosis of Wuchereria bancrofti infections based on detection of speci¢c circulating antigens have been evaluated. These tests are (1) The ICT card test for serum or blood speci-mens (2) The TropBio ELISA for serum specimens. (3) The TropBio ELISA for ¢lter paper specimens. The sensitivity for detecting micro¢laraemic cases was 100% for all three. Furthermore, a signi¢cant correlation with micro¢larial intensity was seen with the TropBio ¢lter paper test (Simonsen & Dunyo1999) .
PCR-ELISA using digoxigenin labelled PCR products hybridized to a biotin-labelled probe followed by incubation in streptavidin coated microtitre wells and detection using antidigoxigenin peroxidase and ABTS is a speci¢c and sensitive method improving on microscopic methods (Rahmah et al. 1998) .
Other micro¢lariae found in peripheral blood are Mansonella ozzardi and Mansonella perstans, each of which can be detected by ¢ltration of day blood samples using a 3-mm rather than a 5-mm pore membrane. They are nonsheathed micro¢lariae and are recognized by their smaller size and blunt tail with a prominent nucleus at the end (M. perstans) or sharply pointed tail free of nuclei (M. ozzardi).
Conclusion
Immunodiagnostic and molecular methods will become increasingly important for the detection and identi¢ca-tion of blood parasites. However, light microscopy will still be required for the foreseeable future, and haematologists should maintain their pro¢ciency in the morphological diagnosis of the common blood parasites of humans, especially malaria.
